Prekyba OPKO Health, Inc. - OPK CFD
Pridėti prie mėgstamų- Santrauka
- Istoriniai duomenys
- Įvykiai
- Pajamų ataskaita
- Balansas
- Pinigų srautai
- Nuosavybė
Prekybos sąlygos
| Skirtumas | 0.0154 | ||||||||
|
Ilgos pozicijos nakties mokestis
Long position overnight fee
Eiti į platformą | -0.030779% | ||||||||
|
Trumpos pozicijos nakties mokestis
Short position overnight fee
Eiti į platformą | -0.013666% | ||||||||
| Nakties mokesčio laikas | 22:00 (UTC) | ||||||||
| Mažiausias parduodamas kiekis | 1 | ||||||||
| Valiuta | USD | ||||||||
| Marža | 20% | ||||||||
| Akcijų birža | United States of America | ||||||||
| Prekybos mokesčiai | 0% |
*Information provided by Capital.com
Pagrindiniai statistiniai duomenys
| Ankstesnis uždarymas* | 1.3872 |
| Atviras* | 1.3872 |
| 1 metų pokytis* | -57.19% |
| Dienos intervalas* | 1.3174 - 1.3972 |
| 52 savaičių intervalas | 1.03-3.78 |
| Vidutinė apimtis (10 dienų) | 2.90M |
| Vidutinė apimtis (3 mėn.) | 53.78M |
| Rinkos kapitalizacija | 1.07B |
| P/E santykis | -100.00K |
| Neišpirktos akcijos | 772.69M |
| Pajamos | 1.22B |
| EPS | -0.45 |
| Dividendai (pajamingumas %) | N/A |
| Beta | 1.63 |
| Kito pelno data | Feb 22, 2023 |
Visus duomenis pateikė Refinitiv, išskyrus žvaigždute pažymėtus duomenis, kurie yra Capital.com pateikti *duomenys
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Uždarymas | Change | Change (%) | Atidarymas | High | Low |
|---|---|---|---|---|---|---|
| Feb 6, 2023 | 1.3373 | 0.0000 | 0.00% | 1.3373 | 1.3972 | 1.3174 |
| Feb 3, 2023 | 1.3872 | -0.0499 | -3.47% | 1.4371 | 1.4970 | 1.3872 |
| Feb 2, 2023 | 1.4272 | 0.0200 | 1.42% | 1.4072 | 1.4272 | 1.3174 |
| Feb 1, 2023 | 1.3772 | 0.1098 | 8.66% | 1.2674 | 1.4272 | 1.2575 |
| Jan 31, 2023 | 1.2774 | 0.0399 | 3.22% | 1.2375 | 1.2874 | 1.2375 |
| Jan 30, 2023 | 1.2275 | 0.0000 | 0.00% | 1.2275 | 1.2575 | 1.2175 |
| Jan 27, 2023 | 1.2475 | 0.0300 | 2.46% | 1.2175 | 1.2774 | 1.2076 |
| Jan 26, 2023 | 1.2475 | -0.0199 | -1.57% | 1.2674 | 1.2675 | 1.2175 |
| Jan 25, 2023 | 1.2974 | 0.0100 | 0.78% | 1.2874 | 1.3174 | 1.2475 |
| Jan 24, 2023 | 1.3174 | -0.0598 | -4.34% | 1.3772 | 1.3772 | 1.2774 |
| Jan 23, 2023 | 1.3772 | -0.0599 | -4.17% | 1.4371 | 1.4471 | 1.3673 |
| Jan 20, 2023 | 1.4870 | 0.0399 | 2.76% | 1.4471 | 1.5070 | 1.4371 |
| Jan 19, 2023 | 1.4671 | -0.1197 | -7.54% | 1.5868 | 1.5869 | 1.4571 |
| Jan 18, 2023 | 1.5968 | 0.0000 | 0.00% | 1.5968 | 1.6667 | 1.5769 |
| Jan 17, 2023 | 1.5769 | 0.0200 | 1.28% | 1.5569 | 1.6567 | 1.5070 |
| Jan 13, 2023 | 1.5669 | 0.2396 | 18.05% | 1.3273 | 1.5869 | 1.3174 |
| Jan 12, 2023 | 1.3174 | 0.0300 | 2.33% | 1.2874 | 1.3174 | 1.2774 |
| Jan 11, 2023 | 1.2974 | 0.0299 | 2.36% | 1.2675 | 1.3074 | 1.2575 |
| Jan 10, 2023 | 1.2575 | 0.0300 | 2.44% | 1.2275 | 1.2575 | 1.2275 |
| Jan 9, 2023 | 1.2275 | 0.0000 | 0.00% | 1.2275 | 1.2675 | 1.1976 |
OPKO Health, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Metinis
- Kas ketvirtį
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Visos pajamos | 1117.49 | 966.006 | 990.266 | 901.935 | 1435.41 | 1774.72 |
| Pajamos | 1117.49 | 966.006 | 990.266 | 901.935 | 1435.41 | 1774.72 |
| Bendros pajamos, iš viso | 611.482 | 620.13 | 604.636 | 572.484 | 894.408 | 1193.19 |
| Pajamos | 506.012 | 345.876 | 385.63 | 329.451 | 541.005 | 581.524 |
| Pajamų sąnaudos, iš viso | 1214.05 | 1242.45 | 1161.46 | 1175.99 | 1377.7 | 1755.97 |
| Pardavimas / Bendrosios / administravimo išlaidos, iš viso | 398.431 | 408.828 | 353.446 | 340.305 | 354.573 | 468.857 |
| Tyrimai ir plėtra | 113.871 | 126.435 | 125.586 | 117.87 | 75.316 | 76.85 |
| Depreciation / Amortization | 64.407 | 71.484 | 67.933 | 64.783 | 56.391 | 50.278 |
| Neįprastos išlaidos (pajamos) | 8.9 | 18.994 | 26.678 | 95.399 | 1 | -31.508 |
| Other Operating Expenses, Total | 16.954 | -3.423 | -16.816 | -14.854 | -3.989 | -1.703 |
| Veiklos pajamos | -96.551 | -276.442 | -171.197 | -274.052 | 57.714 | 18.75 |
| Palūkanų pajamos (išlaidos), grynosios ne veiklos pajamos | -4.174 | -5.939 | -7.607 | -19.632 | -21.732 | -18.006 |
| Kita, pajamos | 3.903 | 10.457 | 1.535 | -11.281 | 12.701 | -14.77 |
| Grynosios pajamos prieš mokesčius | -96.822 | -271.924 | -177.269 | -304.965 | 48.683 | -14.026 |
| Grynosios pajamos po mokesčių | -40.707 | -290.779 | -138.543 | -312.025 | 31.066 | -29.515 |
| Equity In Affiliates | -7.652 | -14.471 | -14.497 | -2.9 | -0.48 | -0.629 |
| Grynosios pajamos prieš papildomas. Prekės | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.144 |
| Grynosios pajamos | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.144 |
| Pajamos, kurias galima gauti bendrai, išskyrus papildomas pajamas. Prekės | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.143 |
| Pajamos, kurias galima gauti bendrai, įskaitant papildomas pajamas. Prekės | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.143 |
| Skiedžiamas grynasis pelnas | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.143 |
| Skiedžiamas svertinis vidutinis akcijų skaičius | 550.847 | 559.161 | 563.144 | 595.454 | 640.655 | 648.078 |
| Skiedžiamas pelnas už akcijas, neįskaitant ypatingų prekių | -0.08779 | -0.54591 | -0.27176 | -0.52888 | 0.04774 | -0.04651 |
| Skiedžiamas normalizuotas pelnas, gautas iš pelno | -0.07729 | -0.52383 | -0.24097 | -0.42474 | 0.04874 | -0.07811 |
| Iš viso nepaprastųjų prekių | 0 | |||||
| Total Adjustments to Net Income | 0.001 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Visos pajamos | 545.165 | 442.408 | 385.813 | 401.331 | 329.219 |
| Pajamos | 545.165 | 442.408 | 385.813 | 401.331 | 329.219 |
| Bendros pajamos, iš viso | 363.507 | 292.908 | 243.957 | 292.823 | 243.875 |
| Pajamos | 181.658 | 149.5 | 141.856 | 108.508 | 85.344 |
| Pajamų sąnaudos, iš viso | 506.728 | 436.837 | 347.987 | 464.415 | 401.643 |
| Pardavimas / Bendrosios / administravimo išlaidos, iš viso | 112.286 | 113.236 | 105.12 | 138.214 | 117.537 |
| Tyrimai ir plėtra | 19.315 | 18.222 | 18.306 | 21.007 | 18.312 |
| Depreciation / Amortization | 12.577 | 12.574 | 12.609 | 12.518 | 22.025 |
| Other Operating Expenses, Total | -0.957 | -0.103 | -0.497 | -0.147 | -0.106 |
| Veiklos pajamos | 38.437 | 5.571 | 37.826 | -63.084 | -72.424 |
| Palūkanų pajamos (išlaidos), grynosios ne veiklos pajamos | -5.829 | -5.153 | -2.998 | -4.026 | -2.784 |
| Kita, pajamos | -0.927 | -11.783 | -3.356 | 1.297 | -1.442 |
| Grynosios pajamos prieš mokesčius | 31.681 | -11.365 | 31.472 | -65.813 | -76.65 |
| Grynosios pajamos po mokesčių | 31.121 | -16.119 | 28.792 | -73.309 | -55.384 |
| Equity In Affiliates | -0.043 | -0.067 | -0.053 | -0.466 | -0.049 |
| Grynosios pajamos prieš papildomas. Prekės | 31.078 | -16.186 | 28.739 | -73.775 | -55.433 |
| Grynosios pajamos | 31.078 | -16.186 | 28.739 | -73.775 | -55.433 |
| Pajamos, kurias galima gauti bendrai, išskyrus papildomas pajamas. Prekės | 31.078 | -16.186 | 28.739 | -73.774 | -55.433 |
| Pajamos, kurias galima gauti bendrai, įskaitant papildomas pajamas. Prekės | 31.078 | -16.186 | 28.739 | -73.774 | -55.433 |
| Skiedžiamas grynasis pelnas | 31.078 | -16.186 | 28.739 | -73.774 | -55.433 |
| Skiedžiamas svertinis vidutinis akcijų skaičius | 640.853 | 646.997 | 651.843 | 652.18 | 660.302 |
| Skiedžiamas pelnas už akcijas, neįskaitant ypatingų prekių | 0.04849 | -0.02502 | 0.04409 | -0.11312 | -0.08395 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Skiedžiamas normalizuotas pelnas, gautas iš pelno | 0.04849 | -0.02502 | 0.01267 | -0.11312 | -0.08395 |
| Neįprastos išlaidos (pajamos) | -31.508 | 0 | |||
| Total Adjustments to Net Income | 0.001 |
- Metinis
- Kas ketvirtį
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Trumpalaikis turtas iš viso | 483.601 | 348.861 | 317.731 | 324.045 | 523.179 | 823.013 |
| Pinigai ir trumpalaikės investicijos | 168.733 | 91.499 | 96.473 | 85.452 | 72.211 | 134.71 |
| Pinigai ir ekvivalentai | 168.733 | 91.499 | 96.473 | 85.452 | 72.211 | 134.71 |
| Gautinos sumos, iš viso, grynąja verte | 249.492 | 192.892 | 161.983 | 157.687 | 302.256 | 265.588 |
| Accounts Receivable - Trade, Net | 220.284 | 165.516 | 143.907 | 134.617 | 286.314 | 259.637 |
| Total Inventory | 47.228 | 49.333 | 42.299 | 53.434 | 132.341 | 86.502 |
| Prepaid Expenses | 10.64 | 11.739 | 13.129 | 11.633 | 11.062 | 15.024 |
| Other Current Assets, Total | 7.508 | 3.398 | 3.847 | 15.839 | 5.309 | 321.189 |
| Total Assets | 2766.62 | 2589.96 | 2451.07 | 2309.27 | 2473.06 | 2399.72 |
| Property/Plant/Equipment, Total - Net | 122.831 | 146.557 | 144.674 | 166.491 | 178.289 | 123.955 |
| Property/Plant/Equipment, Total - Gross | 79.509 | 232.404 | 256.336 | 302.936 | 343.058 | 257.281 |
| Accumulated Depreciation, Total | -56.778 | -85.847 | -111.662 | -136.445 | -164.769 | -133.326 |
| Goodwill, Net | 704.603 | 717.099 | 700.193 | 671.94 | 680.602 | 520.601 |
| Intangibles, Net | 1408.69 | 1331.18 | 1250.02 | 1119.16 | 1065.2 | 911.883 |
| Long Term Investments | 37.122 | 37.309 | 30.373 | 20.626 | 15.731 | 10.729 |
| Other Long Term Assets, Total | 9.773 | 8.948 | 8.077 | 7.008 | 10.06 | 9.534 |
| Total Current Liabilities | 263.296 | 312.029 | 288.321 | 249.119 | 375.483 | 330.008 |
| Accounts Payable | 53.36 | 74.307 | 47.395 | 62.537 | 100.883 | 82.04 |
| Accrued Expenses | 117.066 | 160.588 | 133.476 | 154.891 | 231.661 | 202.602 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 15.006 | 15.325 | 40.693 | 12.362 | 27.156 | 16.952 |
| Other Current Liabilities, Total | 77.864 | 61.809 | 66.757 | 19.329 | 15.783 | 28.414 |
| Total Liabilities | 674.811 | 746.333 | 659.781 | 694.513 | 801.512 | 714.589 |
| Total Long Term Debt | 73.707 | 142.665 | 172.771 | 263.909 | 228.631 | 193.083 |
| Long Term Debt | 66.491 | 134.879 | 167.151 | 259.863 | 225.826 | 190.159 |
| Capital Lease Obligations | 7.216 | 7.786 | 5.62 | 4.046 | 2.805 | 2.924 |
| Deferred Income Tax | 165.331 | 148.729 | 115.193 | 118.717 | 137.208 | 148.487 |
| Other Liabilities, Total | 172.477 | 142.91 | 83.496 | 62.768 | 60.19 | 43.011 |
| Total Equity | 2091.81 | 1843.62 | 1791.29 | 1614.76 | 1671.55 | 1685.13 |
| Common Stock | 5.586 | 5.6 | 5.869 | 6.704 | 6.706 | 6.901 |
| Additional Paid-In Capital | 2845.1 | 2889.26 | 3004.42 | 3142.99 | 3152.69 | 3222.49 |
| Retained Earnings (Accumulated Deficit) | -729.954 | -1048.91 | -1197.08 | -1511.08 | -1481.83 | -1511.98 |
| Treasury Stock - Common | -1.911 | -1.791 | -1.791 | -1.791 | -1.791 | -1.791 |
| Unrealized Gain (Loss) | -0.263 | 4.876 | 0 | |||
| Other Equity, Total | -26.746 | -5.404 | -20.131 | -22.07 | -4.225 | -30.495 |
| Total Liabilities & Shareholders’ Equity | 2766.62 | 2589.96 | 2451.07 | 2309.27 | 2473.06 | 2399.72 |
| Total Common Shares Outstanding | 557.989 | 559.474 | 586.332 | 669.829 | 670.036 | 681.427 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Trumpalaikis turtas iš viso | 599.049 | 547.029 | 557.51 | 823.013 | 754.069 |
| Pinigai ir trumpalaikės investicijos | 89.503 | 65.757 | 148.599 | 134.71 | 102.281 |
| Pinigai ir ekvivalentai | 89.503 | 65.757 | 148.599 | 134.71 | 102.281 |
| Gautinos sumos, iš viso, grynąja verte | 330.293 | 275.639 | 265.527 | 265.588 | 221.295 |
| Accounts Receivable - Trade, Net | 320.462 | 265.856 | 255.192 | 259.637 | 212.755 |
| Total Inventory | 159.104 | 134.722 | 112.861 | 86.502 | 99.406 |
| Prepaid Expenses | 15.086 | 21.967 | 19.52 | 15.024 | 9.902 |
| Other Current Assets, Total | 5.063 | 48.944 | 11.003 | 321.189 | 321.185 |
| Total Assets | 2519.57 | 2421.65 | 2417.64 | 2399.72 | 2306.86 |
| Property/Plant/Equipment, Total - Net | 177.7 | 143.001 | 141.002 | 123.955 | 124.667 |
| Goodwill, Net | 676.162 | 677.36 | 674.574 | 520.601 | 519.052 |
| Intangibles, Net | 1046.51 | 1035.71 | 1024.06 | 911.883 | 890.498 |
| Long Term Investments | 10.41 | 8.945 | 11.753 | 10.729 | 9.472 |
| Other Long Term Assets, Total | 9.745 | 9.6 | 8.744 | 9.534 | 9.1 |
| Total Current Liabilities | 403.93 | 303.98 | 283.035 | 330.008 | 309.17 |
| Accounts Payable | 162.69 | 88.512 | 94.393 | 82.04 | 94.24 |
| Accrued Expenses | 206.106 | 186.79 | 168.936 | 202.602 | 166.297 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 20.103 | 20.045 | 16.702 | 16.952 | 19.863 |
| Other Current Liabilities, Total | 15.031 | 8.633 | 3.004 | 28.414 | 28.77 |
| Total Liabilities | 823.061 | 679.065 | 652.071 | 714.589 | 691.974 |
| Total Long Term Debt | 230.613 | 189.727 | 189.516 | 193.083 | 216.358 |
| Long Term Debt | 228.107 | 187.168 | 187.214 | 190.159 | 212.493 |
| Capital Lease Obligations | 2.506 | 2.559 | 2.302 | 2.924 | 3.865 |
| Deferred Income Tax | 135.244 | 136.416 | 134.247 | 148.487 | 125.03 |
| Other Liabilities, Total | 53.274 | 48.942 | 45.273 | 43.011 | 41.416 |
| Total Equity | 1696.51 | 1742.58 | 1765.57 | 1685.13 | 1614.88 |
| Common Stock | 6.707 | 6.898 | 6.9 | 6.901 | 6.902 |
| Additional Paid-In Capital | 3155.65 | 3214.35 | 3218.58 | 3222.49 | 3191.14 |
| Retained Earnings (Accumulated Deficit) | -1450.76 | -1466.94 | -1438.2 | -1511.98 | -1549.95 |
| Treasury Stock - Common | -1.791 | -1.791 | -1.791 | -1.791 | -1.791 |
| Other Equity, Total | -13.295 | -9.932 | -19.923 | -30.495 | -31.415 |
| Total Liabilities & Shareholders’ Equity | 2519.57 | 2421.65 | 2417.64 | 2399.72 | 2306.86 |
| Total Common Shares Outstanding | 670.153 | 681.163 | 681.342 | 681.427 | 681.483 |
- Metinis
- Kas ketvirtį
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Grynosios pajamos / pradinė eilutė | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.143 |
| Pagrindinės veiklos pinigai | 32.046 | -92.08 | -109.141 | -172.522 | 39.476 | 38.337 |
| Pagrindinės veiklos pinigai | 96.576 | 102.093 | 97.344 | 93.807 | 85.362 | 78.716 |
| Deferred Taxes | -66.3 | 16.092 | -35.133 | 4.324 | 15.64 | 10.159 |
| Nepiniginės prekės | 70.062 | 46.633 | 39.832 | 113.079 | 5.497 | 0.087 |
| Cash Taxes Paid | -27.122 | 5.416 | 1.41 | -2.667 | 0.903 | 5.969 |
| Sumokėtos palūkanos grynaisiais pinigais | 2.89 | 1.313 | 2.076 | 11.873 | 10.908 | 8.515 |
| Apyvartinio kapitalo pokyčiai | -19.933 | 48.352 | -58.144 | -68.807 | -97.609 | -20.482 |
| Investicinės veiklos pinigai | -20.702 | -46.667 | -26.119 | -13.27 | -18.327 | 35.949 |
| Kapitalo išlaidos | -23.547 | -46.524 | -27.858 | -12.741 | -33.682 | -32.156 |
| Kiti investiciniai pinigų srautų iš prekių, iš viso | 2.845 | -0.143 | 1.739 | -0.529 | 15.355 | 68.105 |
| Finansinės veiklos pinigai | -35.195 | 61.043 | 140.909 | 175.248 | -35.076 | -10.351 |
| Akcijų išleidimas (išpirkimas), grynasis | 8.576 | 2.132 | 148.673 | 276.352 | 0.756 | 1.08 |
| Skolos išleidimas (padengimas), grynasis | -43.771 | 58.911 | -7.764 | -93.342 | -35.832 | -11.243 |
| Užsienio valiutos keitimo įtaka | -1.014 | 0.47 | -0.675 | -0.477 | 0.686 | -1.436 |
| Grynasis pinigų pokytis | -24.865 | -77.234 | 4.974 | -11.021 | -13.241 | 62.499 |
| Finansavimo pinigų srautų prekės | -7.762 | 0 | -0.188 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 31.078 | 14.892 | 43.631 | -30.143 | -55.433 |
| Cash From Operating Activities | 26.037 | 10.584 | 43.98 | 38.337 | -19.856 |
| Cash From Operating Activities | 19.989 | 40.561 | 59.525 | 78.716 | 27.814 |
| Deferred Taxes | -1.033 | 2.479 | 2.378 | 10.159 | -22.356 |
| Non-Cash Items | 1.222 | 19.401 | -9.952 | 0.087 | 9.879 |
| Cash Taxes Paid | 1.47 | 3.69 | 5.509 | 5.969 | 1.063 |
| Cash Interest Paid | 4.689 | 4.883 | 8.386 | 8.515 | 3.42 |
| Changes in Working Capital | -25.219 | -66.749 | -51.602 | -20.482 | 20.24 |
| Cash From Investing Activities | -1.106 | -9.948 | 44.628 | 35.949 | -4.903 |
| Capital Expenditures | -9.245 | -18.192 | -25.426 | -32.156 | -5.251 |
| Other Investing Cash Flow Items, Total | 8.139 | 8.244 | 70.054 | 68.105 | 0.348 |
| Cash From Financing Activities | -7.192 | -6.927 | -11.183 | -10.351 | -7.891 |
| Issuance (Retirement) of Stock, Net | 0.308 | 0.466 | 0.879 | 1.08 | 0.136 |
| Issuance (Retirement) of Debt, Net | -7.5 | -7.393 | -11.874 | -11.243 | -8.027 |
| Foreign Exchange Effects | -0.447 | -0.163 | -1.037 | -1.436 | 0.221 |
| Net Change in Cash | 17.292 | -6.454 | 76.388 | 62.499 | -32.429 |
| Financing Cash Flow Items | -0.188 | -0.188 |
| Investuotojo pavadinimas | Investuotojo tipas | Apyvartoje esantis procentas | Turimos akcijos | Turimų akcijų pokytis | Turėjimo data | Apyvartos vertinimas |
|---|---|---|---|---|---|---|
| Frost Gamma Investments Trust | Corporation | 26.405 | 204027475 | 200000 | 2022-11-23 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 5.2039 | 40209654 | -2296471 | 2022-09-30 | LOW |
| Holbrook (Bruce C) | Individual Investor | 5.1484 | 39781126 | 39781126 | 2022-05-10 | |
| Hsiao (Jane H) | Individual Investor | 4.2355 | 32727274 | 0 | 2022-07-28 | |
| Frost Group, L.L.C. | Corporation | 3.899 | 30127177 | 0 | 2022-08-17 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.8394 | 29666569 | -351756 | 2022-09-30 | LOW |
| GJN 2021 Trust | Corporation | 2.5699 | 19857514 | 19857514 | 2022-06-22 | |
| EGN 2021 Trust | Corporation | 2.5699 | 19857514 | 19857514 | 2022-06-22 | |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.4008 | 10823641 | 1744961 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.3426 | 10374273 | 507764 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0132 | 7829188 | 200456 | 2022-09-30 | LOW |
| Rubin (Steven D) | Individual Investor | 0.7969 | 6157732 | 0 | 2022-05-23 | |
| D. E. Shaw & Co., L.P. | Hedge Fund | 0.7724 | 5968306 | -397910 | 2022-09-30 | HIGH |
| Oracle Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.6604 | 5102756 | -2150000 | 2022-09-30 | MED |
| Two Sigma Investments, LP | Hedge Fund | 0.6484 | 5009766 | 2467029 | 2022-09-30 | HIGH |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.5534 | 4276383 | 1215448 | 2021-12-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.4935 | 3813530 | 420857 | 2022-09-30 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.4461 | 3446571 | -87509 | 2022-09-30 | LOW |
| Invesco Capital Management LLC | Investment Advisor | 0.4186 | 3234077 | 709875 | 2022-09-30 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.3671 | 2836343 | -1053829 | 2022-09-30 | HIGH |
Kodėl Capital.com? Mūsų skaičiai kalba už save.
Capital.com Group +485000+
Prekeiviai
65000+
Aktyvūs klientai kas mėnesį
$48000000+
Mėnesio investicijų apimtis
$28000000+
Išbandykite dabar Atsiimama kas mėnesį
Prekybos skaičiuoklė
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Sandorio komisiniai mokesčiai
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Svertas
20:1
- 20
- 100
- 500
- 1000
- 10000
Investavimas
Sandorio dydis (finansinis svertas x investicija):
Atidarymas
Uždarymas
Trumpoji Ilgoji
OPKO Health, Inc. Company profile
Apie OPKO Health, Inc.
"OPKO Health, Inc." yra sveikatos priežiūros bendrovė. Bendrovės segmentai - diagnostika ir farmacija. Diagnostikos segmentą sudaro klinikinės laboratorijos "Bio-Reference Laboratories" ("Bio-Reference") klinikinė laboratorinė veikla ir jos priežiūros taškų veikla. Farmacijos segmentą sudaro farmacijos veikla Čilėje, Meksikoje, Airijoje, Izraelyje ir Ispanijoje bei farmacijos mokslinių tyrimų ir plėtros veikla. Per "Bio-Reference" ji valdo laboratorijų padalinius, tokius kaip "Bio-Reference", "GenPath" (onkologija), "GenPath" (moterų sveikata) ir "GeneDx". Jos farmacijos versle yra vienas komercinės stadijos farmacijos produktas ir keletas farmacijos junginių ir technologijų, esančių įvairiose mokslinių tyrimų ir plėtros stadijose, skirtų įvairioms indikacijoms ir būklėms, įskaitant inkstų produktus, oksintomoduliną, biologinius vaistus, VIIa faktorių -CTP ir hGH-CTP. Ji taip pat turi aktyviųjų farmacinių ingredientų (API) gamintoją Izraelyje per savo patronuojamąją įmonę "FineTech Pharmaceutical, Ltd.".
| Industry: | Pharmaceuticals (NEC) |
4400 Biscayne Blvd.
MIAMI
FLORIDA 33137
US
Pajamų ataskaita
- Annual
- Quarterly
Žmonės taip pat žiūri
Vis dar ieškote brokerio kuriuo galėtumėte pasitikėti?
Prisijunkite prie 485 000+ prekeivių visame pasaulyje, kurie pasirinko prekybą su Capital.com